Low-dose paclitaxel downregulates MYC proto-oncogene bHLH transcription factor expression in colorectal carcinoma cells

Paclitaxel (PTX) has been commonly used to treat multiple types of tumor. Its anticancer mechanism differs based on different PTX concentrations and types of tumor cell. In the present study, MTT assays of HCT116 and LOVO cells treated with PTX revealed the chemosensitivity of the cell lines for dif...

Full description

Saved in:
Bibliographic Details
Published in:Oncol Lett
Main Authors: Li, Wenjing, Zhu, Wanyun, Lv, Chaoxiang, Qu, Hao, Xu, Kaixiang, Li, Honghui, Li, Haifeng, Du, Yiming, Liu, Guangming, Wang, Yunyue, Wei, Hong-Jiang, Zhao, Hong-Ye
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2018
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5776885/
https://ncbi.nlm.nih.gov/pubmed/29434885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7525
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items